The weekly litigation news digest is live. Subscribe now

IP Verse

Pharmaceutical Composition And Administrations Thereof - EP3345625

The patent EP3345625 was granted to Vertex Pharmaceuticals Incorporated on Dec 9, 2020. The application was filed on Aug 13, 2009 under application number EP17204189A. The patent is currently recorded with a legal status of "Revoked".

EP3345625

VERTEX PHARMACEUTICALS INCORPORATED
Application Number
EP17204189A
Filing Date
Aug 13, 2009
Status
Revoked
May 9, 2025
Publication Date
Dec 9, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
STADA ARZNEIMITTELSep 9, 2021HAMM & WITTKOPPADMISSIBLE
KRAUS & LEDERER PARTGMBBSep 7, 2021KRAUS & LEDERER PARTGMBBADMISSIBLE
TEVA PHARMACEUTICALSSep 6, 2021D YOUNGADMISSIBLE

Patent Citations (5) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS2004006237
DESCRIPTIONWO2007079139
OPPOSITIONWO2007079139
OPPOSITIONWO2008080167
SEARCHWO2007079139

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents